The rate of diabetes-related myocardial infarction has fallen almost 68% since 1990, according to an analysis of several federal data sources.
From 1990 to 2010, the rate of acute MI among adults...
Albiglutide, a once-weekly subcutaneous injection, has been approved by the Food and Drug Administration to improve glycemic control, in conjunction with diet and exercise in type 2...
Increasing maternal body mass index shows a moderate to strong dose-response relationship with increasing risks of fetal death, stillbirth, neonatal death, perinatal death, and infant death,...
Increasing maternal body mass index shows a moderate to strong dose-response relationship with increasing risks of fetal death, stillbirth, neonatal death, perinatal death, and infant death,...
A 6-year program of diet, exercise, or both helped delay the onset of diabetes in adults, and had significant mortality benefits for women 23 years later, researchers reported online in the Lancet...
The prevalence of diagnosed diabetes in the United States rose significantly from 1988 to 2010, jumping from 6% to 10%.
Prediabetes doubled in prevalence over the same time period, from 6% to 12%,...
Once-daily liraglutide slightly outperformed once-weekly albiglutide in a head-to-head trial in adults with poorly controlled type 2 diabetes, researchers reported in the April issue of the Lancet...
In patents with type 2 diabetes, weekly injections with exenatide controlled hemoglobin A1c levels more effectively than did daily glargine over a 3-year period, investigators reported...
WASHINGTON – "We’re at the dawn of an era of biological therapeutics in cardiology," Dr. Peter Libby, chief of cardiovascular medicine at the Brigham and Women’s Hospital in Boston, told us...